▲ Peaking
Health
High-fiber diet vs metformin: Which is better for blood sugar control, weight loss?
A October 18 trial suggests a high‑fiber diet may match metformin for glucose control while outpacing it on weight loss.
Type 2 Diabetes
31 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Type 2 Diabetes
This hub groups 31 separate news trends connected to Type 2 Diabetes, spanning June 20, 2026 through October 19, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 256 article observations and 246 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
▲ Peaking
Health
🔮 fades ✓
NEWSLETTER: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin
Continuous glucose monitors, once limited to insulin users, now prove benefits for non‑insulin type 2 diabetics, reshaping diabetes care.
◼ Archived
Health
🔮 fades ✓
This Diet And Exercise Combination Put Early-Onset Diabetes Into Remission in Half of Participants
Half of early‑onset type 2 diabetes patients entered remission after a low‑energy diet and structured exercise, per a new study.
◼ Archived
Health
🔮 fades ✓
These Seemingly Minor Symptoms Could Actually Be Signs Of Diabetes
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Researchers followed glucose monitor users for three years and found a possible kidney benefit - News-Medical
Thousands of people may live longer thanks to a common diabetes tool.
◼ Archived
Health
🔮 fades ✓
Continuous Glucose Monitoring and Long-Term Glycemic and Kidney Outcomes
Continuous glucose monitors may protect kidneys from early damage caused by diabetes.
◼ Archived
Health
🔮 fades ✓
Scientists May Have Found How to Limit Weight Regain After Stopping GLP-1s
Scientists May Have Found a Way to Limit Weight Regain After Stopping GLP-1 Medicines
◼ Archived
Health
🔮 fades ✓
Probing the many benefits of GLP-1 receptor agonists
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Scientists Reveal The Optimal Amount of Sleep For Lower Dementia Risk
New analyses link just seven to eight hours of quality sleep to a drop in dementia and dozens of other diseases.
◼ Archived
Health
🔮 fades ✓
Navigating GLP-1 Switches: A Guide for Primary Care
Thousands of people are struggling to maintain weight loss after switching from GLP-1 medications.
◼ Archived
Business
🔮 fades ✓
People with Type 2 diabetes lost up to 60 pounds on Lilly’s latest weight loss drug
People with Type 2 diabetes lose up to 60 pounds on Lilly’s latest weight loss drug
◼ Archived
Health
🔮 fades ✓
Kidney disease, heart failure or death risk climbs to 55% 10 years after type 2 diabetes diagnosis
Rising risk of heart failure, kidney disease, or death for those with type 2 diabetes
◼ Archived
Health
🔮 fades ✓
Is long-term use of GLP-1s safe?
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
Study finds link between GLP-1 drugs and nutritional deficiencies in children
◼ Archived
Health
🔮 fades ✓
The dangerous risks of stopping Ozempic and GLP-1s
18 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
Doctors Just Found This Common Class of Drugs Is Linked to Lower Risk of Dementia
Common class of drugs linked to lower dementia risk
◼ Archived
Health
🔮 fades ✓
Study defines early-onset cirrhosis caused by fatty liver disease - News-Medical
14 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
What are statins? And can healthy people use them to prevent heart disease and dementia?
Early statin therapy after a type‑2 diabetes diagnosis is linked to a 15% dip in dementia cases, sparking debate over preventive use.
◼ Archived
Health
🔮 fades ✓
GLP-1 medications may worsen or speed hair loss in some men, study finds
GLP-1 medications may worsen or speed hair loss in some men, study finds.
◼ Archived
Health
🔮 fades ✓
Don’t take GLP-1s? Be prepared to explain yourself.
A surge in GLP‑1 prescriptions turns personal weight‑loss choices into a public debate demanding explanations.
◼ Archived
Business
🔮 fades ✓
FDA approves new use of popular diabetes drug
The FDA's approval of a new use for the diabetes drug Mounjaro is trending, with five outlets reporting on the expanded indication.
◼ Archived
Health
🔮 fades ✓
Diabetes impacts men, women differently: Study
A 2026 Queen Mary study shows type 2 diabetes shortens men’s lives by a decade while raising women’s mental‑health risk.
◼ Archived
Health
🔮 fades ✓
Statins can reduce dementia risk by up to 15%, long-term study suggests
A cholesterol pill may cut dementia risk by 15% for diabetics, sparking debate over a new use for statins.
◼ Archived
Health
Scientists Find Just 3 Minutes of Sprinting Can Transform Blood Chemistry
New scientific findings suggest that three minutes of sprinting can alter blood chemistry and stimulate protective proteins in ways longer sessions cannot.
◼ Archived
Health
Scientists Found a Surprisingly Simple Way to Cut Your Type 2 Diabetes Risk
A new study suggests that gardening may significantly lower the risk of type 2 diabetes.
◼ Archived
Health
🔮 fades ✓
Type 2 Diabetes: GLP-1 Mounjaro May Lower Heart Attack Risk
A popular diabetes drug may also protect against heart attacks, but the mechanism is still unclear.
◼ Archived
Health
🔮 fades ✓
‘Temporal wasting’: The GLP-1 side effect that makes patients ‘look suddenly older’
A side effect of popular weight-loss drugs is causing patients to appear older.
◼ Archived
Health
🔮 fades ✓
More young women in their 20s are getting type 2 diabetes
Health officials are warning of a 'health time bomb' as Type 2 diabetes cases surge among women in their 20s and those under 40.
◼ Archived
Health
🔮 fades ✗
Low-protein ‘longevity diet’ helped mice live healthier, leaner lives: Study
A new study suggests a low-protein 'longevity diet' may help reduce body fat and increase natural GLP-1 levels.
◼ Archived
Health
🔮 fades ✓
Ozempic and Wegovy may strengthen bones in Type 2 diabetes patients, study finds
New study data suggests GLP-1 medications like Ozempic and Wegovy may reduce fracture risks and improve bone health in Type 2 diabetes patients.